ABCAM PLC: Upcoming Abcam Investor Events
Abcam plc, a leading global supplier of life science research tools, has announced upcoming investor events. Michael Baldock, the Chief Financial Officer, will present at two conferences: the Bank of America 2023 Health Care Conference on May 9, 2023, and William Blair's 43rd Annual Growth Stock Conference on June 6, 2023. These events are significant for investors and will be accessible via a live audio webcast on Abcam's corporate website. Abcam aims to enhance the life sciences sector by providing validated antibodies, assays, and research tools. The company supports approximately 750,000 researchers across over 130 countries, continuously improving its offerings based on customer feedback. Founded in 1998 and headquartered in Cambridge, UK, Abcam's American Depositary Shares are traded on Nasdaq under the symbol ABCM.
- Upcoming investor presentations may enhance investor relations and market visibility.
- Strong customer base of approximately 750,000 researchers indicates robust demand.
- Company's commitment to continuous improvement through customer feedback may drive innovation.
- None.
CAMBRIDGE, England and WALTHAM, Mass., April 17, 2023 /PRNewswire/ -- Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the following investor events.
- Michael Baldock, Chief Financial Officer, will present at two upcoming investor conferences
- Bank of America 2023 Health Care Conference on Tuesday, May 9 at 10:40am PDT
- William Blair's 43rd Annual Growth Stock Conference on Tuesday, June 6 at 12:40pm CDT
The live audio webcast will be available in the investor section of Abcam's corporate website at corporate.abcam.com/investors/reports-presentations/. An archive will be available after the call at that same address.
About Abcam plc
As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays, and other research tools to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.
Abcam's worldwide customer base of approximately 750,000 life science researchers' uses Abcam's antibodies, reagents, biomarkers, and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. A transparent program of customer reviews and datasheets, combined with industry-leading validation initiatives, gives researchers increased confidence in their results.
Founded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. Abcam's American Depositary Shares (ADSs) trade on the Nasdaq Global Select Market (Nasdaq: ABCM).
For more information, please visit www.abcam.com or www.abcamplc.com
For further information please contact:
Abcam plc
Tommy Thomas, CPA
Vice President, Investor Relations
+1 617-577-4205
152 Grove Street, Building 1100
Waltham, MA 02453
tommy.thomas@abcam.com
617-577-4205
Logo - https://mma.prnewswire.com/media/1670705/Abcam_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/abcam-plc-upcoming-abcam-investor-events-301797196.html
SOURCE Abcam PLC
FAQ
What are the upcoming investor events for Abcam in May and June 2023?
Who is presenting at the Abcam investor conferences?
Where can I watch the Abcam investor presentations?
What is Abcam's customer base?
What is the stock symbol for Abcam?
